Literature DB >> 24221505

Translation into Brazilian Portuguese, cross-cultural adaptation and validation of the Stanford presenteeism scale-6 and work instability scale for ankylosing spondylitis.

Renata Frauendorf1, Marcelo de Medeiros Pinheiro, Rozana Mesquita Ciconelli.   

Abstract

Loss of productivity at work, as a result of health problems, is becoming an issue of interest due to the high burden it represents in society. The measurement of such phenomenon can be made using generic and specific scales for certain diseases such as the Stanford Presenteeism Scale (SPS-6) and the Work Instability Scale for Ankylosing Spondylitis (AS-WIS), specific for patients with ankylosing spondylitis (AS). The aim of this study was to translate and perform a cross-cultural adaptation of SPS-6 and AS-WIS into Portuguese and check their psychometric properties. The study also aimed to evaluate the relationship between the general scores of the scales and the main sociodemographic and clinical data, lifestyles, and absenteeism in patients with AS and correlate these variables with SPS-6 and AS-WIS scales. A sample of 120 patients with AS and 80 workers at a university hospital was evaluated. The processes for the translation and cross-cultural adaptation of the instruments followed preestablished steps and rules presented in the literature. For the evaluation of measurement properties and correlations between scales, intra-class correlation coefficient (reproducibility analysis), Cronbach alpha (internal consistency), and Pearson correlation coefficient (validity) were employed. The inter-observer (0.986) and intra-observer (0.992) reproducibilities of the AS-WIS were shown to be high as well as the internal consistency (0.995). Similarly, the inter-observer reliability of SPS-6 was considered good (0.890), although it showed a poorer performance when considering the same observer (Pearson correlation coefficient = 0.675 and intra-class correlation = 0.656). Internal consistency, for the total number of items, as measured by Cronbach alpha, was 0.889. The validity of the scales was evaluated thru the comparison of the achieved scores with the results of the WLQ, SF-36, ASQoL, BASFI, BASDAI, HAQ-S, and SRQ-20 instruments. Correlations between loss of productivity at work, worse quality of life, presence of emotional disturbances, and worse health conditions were positive. The process of translation, cross-cultural adaptation, and validation of the SPS-6 as a generic measurement for the loss of productivity at work and of the AS-WIS as a specific measurement for patients with AS are valid, reproducible, and specific instruments to be used in Brazil. In both scales, productivity at work was associated to advanced age, higher rate of absenteeism in the last month and year, presence of peripheral arthritis, and a larger number of comorbidities in patients with AS. The AS-WIS and SPS-6 showed a good correlation among them although they are not mutually exclusive but supplementary.

Entities:  

Mesh:

Year:  2013        PMID: 24221505     DOI: 10.1007/s10067-013-2429-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  The association of medical conditions and presenteeism.

Authors:  Wayne N Burton; Glenn Pransky; Daniel J Conti; Chin-Yu Chen; Dee W Edington
Journal:  J Occup Environ Med       Date:  2004-06       Impact factor: 2.162

2.  Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers.

Authors:  Ron Z Goetzel; Stacey R Long; Ronald J Ozminkowski; Kevin Hawkins; Shaohung Wang; Wendy Lynch
Journal:  J Occup Environ Med       Date:  2004-04       Impact factor: 2.162

Review 3.  A review of health-related workplace productivity loss instruments.

Authors:  Jennifer H Lofland; Laura Pizzi; Kevin D Frick
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  [Factor structure and internal consistency of the Self-Reporting Questionnaire (SRQ-20) in an urban population].

Authors:  Kionna Oliveira Bernardes Santos; Tânia Maria de Araújo; Nelson Fernandes de Oliveira
Journal:  Cad Saude Publica       Date:  2009-01       Impact factor: 1.632

Review 5.  The burden of ankylosing spondylitis.

Authors:  Annelies Boonen; Sjef M van der Linden
Journal:  J Rheumatol Suppl       Date:  2006-09

6.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

7.  Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis.

Authors:  Walter P Maksymowych; Katherine L Gooch; Robert L Wong; Hartmut Kupper; Désirée van der Heijde
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

8.  Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS).

Authors:  M M Pinheiro; R M Ciconelli; L A Martini; M B Ferraz
Journal:  Osteoporos Int       Date:  2008-07-03       Impact factor: 4.507

9.  Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis.

Authors:  J Listing; J Brandt; M Rudwaleit; A Zink; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

10.  Reducing work disability in Ankylosing Spondylitis: development of a work instability scale for AS.

Authors:  Gill Gilworth; Paul Emery; Nick Barkham; M Glyn Smyth; Philip Helliwell; Alan Tennant
Journal:  BMC Musculoskelet Disord       Date:  2009-06-16       Impact factor: 2.362

View more
  1 in total

1.  Discriminative and Predictive Analysis of the Brazilian Version of the Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) Short-Form in Patients With Low Back Pain.

Authors:  Fernanda F Fuhro; Felipe R C Fagundes; Ana Carolina T Manzoni; Cristina M N Cabral
Journal:  J Chiropr Med       Date:  2022-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.